Indian Government Limiting Access To New TB Drug In Private Sector

Reuters: New drugs still out of reach for most in India, world TB hotspot
“…The government approved the drug bedaquiline in January for about 500 patients under a national TB control program. It is intended for patients with an extremely resistant form of the infection and are immune to existing drugs. But it has no plans yet to make the drug available to the private sector, which is where more than half of the three million afflicted with the deadly infection go for treatment…” (Siddiqui, 3/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.